Current research demonstrated that DE inhibits the growth of three kinds of chemo-resistant cancer cells (IC50 lower than 10 μg/mL) by reducing the expression of ABCB1/MDR1 and ABCG2/BCRP1, indicating that this compound has a potential to circumvent multidrug resistance in these cells [44]. This evidence concerns the gene ABCB1 and cancer.